KELLY STRAIGHT: Open Payments
NPI 1952916660 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 6 payments from 5 companies in 2025. Trend: 2023 $340 · 2024 $677 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 2 | $241 |
| Galderma Laboratories, L.P. | 1 | $140 |
| Edwards Lifesciences Corporation | 1 | $137 |
| Neurelis, Inc. | 1 | $134 |
| ARGENX US, INC. | 1 | $115 |
Products named: NUPLAZID, NEMLUVIO, SAPIEN 3 Ultra RESILIA, VALTOCO, VYVGART.
Industry payments across CA — which companies pay providers there.
